Literature DB >> 16699304

Long-term quiescence of ectopic Cushing's syndrome caused by pulmonary neuroendocrine tumor (typical carcinoid) and tumorlets: spontaneous remission or therapeutic effect of bromocriptine?

G Francia1, M V Davì, E Montresor, C Colato, M Ferdeghini, V Lo Cascio.   

Abstract

In 1990, a 55-yr-old woman was admitted to the Medical Department of our hospital for severe hypercortisolism complicated by secondary diabetes mellitus and serious hypokalemia. Although inferior petrosal sinus sampling did not show any significant difference between central and peripheral ACTH concentration, suggesting an ectopic source of ACTH secretion, diagnostic imaging was negative and Cushing's disease due to hyperplasia of the pituitary intermediate lobe was suspected. Medical treatment with bromocriptine and cyproheptadine led to a rapid and stabile normalization of adrenal function, so that after two months cyproheptadine was stopped and bromocriptine was tapered to a smaller dose. An attempt to discontinue medical treatment, carried out 3 yr later, was followed by a quick increase of ACTH and cortisol levels, which were normalized by the resumption of the bromocriptine. Adrenal function remained normal until 1994 when hypercortisolism relapsed despite the treatment. Chest radiography and computed tomography (CT) scan detected a 6 mm nodule in the middle lobe of the lung which proved to be a neuroendocrine tumor, with immunohistochemical positivity for ACTH. Nests of neuroendocrine cells (tumorlets) were also demonstrated in the surrounding lung tissue. After the lobectomy, the patient recovered completely from Cushing's syndrome and no symptoms and/or signs of recurrence have been observed over the subsequent follow-up period. Although cyclical spontaneous Cushing's syndrome could not be excluded, there was strong evidence that medical treatment with bromocriptine might have played a key role in long-lasting remission. To our knowledge, this is the second case described in literature of Cushing's syndrome caused by neuroendocrine lung tumor responsive to bromocriptine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699304     DOI: 10.1007/BF03344109

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   5.467


  23 in total

1.  Cushing's syndrome caused by ectopic corticotropin secretion by multiple peripheral pulmonary carcinoids and tumorlets of carcinoid type.

Authors:  N Ozbey; A Bozbora; G Kalayci; Y Kapran; D Yilmazbayhan; F Dizdaroglu; Y Orhan; E Sencer; S Molvalilar
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

2.  A study of corticotroph adenomas in Cushing's disease: no evidence of intermediate lobe origin.

Authors:  A M McNicol; G M Teasdale; G H Beastall
Journal:  Clin Endocrinol (Oxf)       Date:  1986-06       Impact factor: 3.478

3.  Periodic hormonogenesis--a new phenomenon. Periodicity in function of a hormone-producing tumor in man.

Authors:  R E Bailey
Journal:  J Clin Endocrinol Metab       Date:  1971-03       Impact factor: 5.958

4.  Cushing syndrome with cyclical edema and periodic secretion of corticosteroids.

Authors:  T Chajek; H Romanoff
Journal:  Arch Intern Med       Date:  1976-04

5.  The histogenesis and development of pulmonary tumorlets.

Authors:  M Ranchod
Journal:  Cancer       Date:  1977-03       Impact factor: 6.860

6.  Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors.

Authors:  G Arnaldi; T Mancini; B Kola; G Appolloni; S Freddi; C Concettoni; I Bearzi; A Masini; M Boscaro; F Mantero
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

7.  Expression of dopamine receptors and transporter in neuroendocrine gastrointestinal tumor cells.

Authors:  K Lemmer; G Ahnert-Hilger; M Höpfner; S Hoegerle; S Faiss; P Grabowski; M Jockers-Scherübl; E O Riecken; M Zeitz; H Scherübl
Journal:  Life Sci       Date:  2002-06-28       Impact factor: 5.037

8.  A case of ectopic ACTH syndrome: diagnostic difficulties caused by intermittent hormone secretion.

Authors:  M O Thorner; W H Martin; G E Ragan; R M MacLeod; P S Feldman; C Bruni; B R Williamson; D N Orth
Journal:  Acta Endocrinol (Copenh)       Date:  1982-03

9.  Pituitary adenomas in Cushing's disease: do they arise from the intermediate lobe?

Authors:  C Raffel; J E Boggan; L F Eng; R L Davis; C B Wilson
Journal:  Surg Neurol       Date:  1988-08

10.  [Unique type of Cushing's disease in clinical profile: cyclic Cushing's syndrome and Cushing's disease with favorable outcome to a high daily dose of bromocriptine].

Authors:  K Yasuda; K Miura
Journal:  Nihon Naibunpi Gakkai Zasshi       Date:  1994-01-20
View more
  4 in total

Review 1.  Cardiothoracic manifestations of neuroendocrine tumours.

Authors:  Ramin Mandegaran; Sarojini David; Nicholas Screaton
Journal:  Br J Radiol       Date:  2016-01-19       Impact factor: 3.039

2.  Cushing's syndrome due to ectopic ACTH production by (neuroendocrine) prostate carcinoma.

Authors:  R A Alwani; S J C M M Neggers; M van der Klift; M G A Baggen; G J L H van Leenders; M O van Aken; A J van der Lely; W W de Herder; R A Feelders
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 3.  Ectopic Cushing's syndrome due to thymic neuroendocrine tumours: a systematic review.

Authors:  Fernando Guerrero-Pérez; Inmaculada Peiró; Agustina Pia Marengo; Alex Teulé; José Carlos Ruffinelli; Roger Llatjos; Teresa Serrano; Ivan Macia; Nuria Vilarrasa; Pedro Iglesias; Carles Villabona
Journal:  Rev Endocr Metab Disord       Date:  2021-05-07       Impact factor: 6.514

Review 4.  Role of "old" pharmacological agents in the treatment of Cushing's syndrome.

Authors:  A G Ambrogio; F Cavagnini
Journal:  J Endocrinol Invest       Date:  2016-04-16       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.